0002149298-26-000001.txt : 20260911 0002149298-26-000001.hdr.sgml : 20260911 20260911141919 ACCESSION NUMBER: 0002149298-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260911 DATE AS OF CHANGE: 20260911 EFFECTIVENESS DATE: 20260911 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Savannah Therapeutics, Inc CENTRAL INDEX KEY: 0002149298 ORGANIZATION NAME: EIN: 414696970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-597238 FILM NUMBER: 261373892 BUSINESS ADDRESS: STREET 1: 16192 COASTAL HIGHWAY CITY: LEWES STATE: DE ZIP: 19958 BUSINESS PHONE: 302-645-7400 MAIL ADDRESS: STREET 1: 7201 WALKER ST STREET 2: SUITE 20 CITY: MINNEAPOLIS STATE: MN ZIP: 55426 D 1 primary_doc.xml X0708 D LIVE 0002149298 Savannah Therapeutics, Inc 5650 Rivertech Court Suite 20 Riverdale MD MARYLAND 20737 6514910507 DELAWARE None None Corporation true 2026 Thomas Wollan 4513 Gilford Drive Edina MN MINNESOTA 55435 Executive Officer Matthew Dowling 2817 Hampden Avenue Baltimore MD MARYLAND 21211 Director Other Health Care No Revenues 06b false 2026-04-17 true true true 25000 6000000 3855000 2145000 true 3 28 0 0 None 576513 true false Savannah Therapeutics, Inc Jason Krause Jason Krause Attorney/Authorized Representative 2026-09-11